News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Moore Matthew Richard
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
4
| Moore Matthew Richard (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 1,589 shares
@ $15.8177, valued at
$25.1k
Sold 21 shares
@ $16.52, valued at
$346.9
Granted 14,900 shares
@ $0
Granted 39,500 options to buy
@ $15.82, valued at
$624.9k
|
|
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2021 |
4
| Moore Matthew Richard (SVP and Chief Business Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $28.72, valued at
$2.3M
|
|
|
|